Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered through one-on-one sessions with a Certified Respiratory Educator (CRE) over 12 weeks. It includes six sessions that cover essential COPD topics such as: Basic COPD knowledge, Smoking cessation, Medications (inhalers, oxygen), Physical activity, Mental health and wellness, Vaccinations, Symptom self-management, Nutrition, Travel, and Long-term planning (including end-of-life care). The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app on the participants phones, tablets, or desktops. This study will evaluate the feasibility and effectiveness of MLHC and the companion app.
My Lung Health Coach (MLHC) is a freely available evidence-based and person-centered COPD self-management program that connects people virtually with experienced certified respiratory educators (CREs) to provide structured COPD education and self-management support. MLHC was jointly developed by the Lung Health Foundation (a charitable organization focused on lung health advocacy) and academic Respirologist Dr. Andrew Kouri, with input from community members living with COPD. MLHC links community members living with COPD with certified respiratory health educators, using a person-centred approach to provide COPD education and self-management support. It is delivered virtually through one-on-one meetings offered over multiple sessions over 12 weeks. The topics covered in the program include: general COPD knowledge, smoking cessation, COPD medications (inhalers, oxygen), physical activity counselling, mental health and wellness, vaccinations, symptom self-management skills (breathing, energy management, symptom monitoring), nutrition, travel, and long-term planning (including end-of-life care).
To improve the patient experience using MLHC, the investigators have integrated the MLHC program into the Epic Care Companion app at Women's College Hospital, an interactive patient-facing app designed as an extension of the Epic electronic health record system. Using Care Companion, patients will be able to track their progress through MLHC, accomplish session-specific educational and self-management tasks, and share their progress with their Women's College healthcare teams.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single Arm Behavioral | Experimental | Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered by a Certified Respiratory Educator (CRE) over 12 weeks. The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app. This study will evaluate the feasibility and effectiveness of MLHC and the companion app. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| My Lung Health Coach | Behavioral | Virtual education and self-management program with companion application |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility (system use): Number of patients who started program over total offered, over one year. | Number of patients who started program over total offered for one year. | 1 year |
| Feasibility (system use): Number of patients who completed program over total started, over one year. | Number of patients who completed program over total started for one year. | 1 year |
| Feasibility (system use): Number of providers who referred patients to the program over total Number of providers, over approximately one year. | Number of providers who referred patients to the program over total Number of providers, over approximately one year. | 1 year |
| Effectiveness (clinical outcomes): Number of COPD-related outpatient visits | Number of COPD-related outpatient visits | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): Hospital admissions | Hospital admissions | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): ED visits | ED visits | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): ICU admissions (at baseline will be over the previous 12 months) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andrew Kouri, MD | Contact | (416) 323-6400 | andrew.kouri@wchospital.ca | |
| kinza ahmed, Bsc | Contact | 6478941963 | kinza.ahmed@wchospital.ca |
| Name | Affiliation | Role |
|---|---|---|
| Andrew Kouri, MD | Womens College Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Womens College Hospital | Recruiting | Toronto | Ontario | M5S 1B2 | Canada |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | May 28, 2024 | Dec 4, 2024 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
ICU admissions (at baseline will be over the previous 12 months) |
| outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): COPD severity as measured by the COPD assessment test (CAT) | COPD severity as measured by the COPD assessment test (CAT) | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): Medication | Medication | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): Referrals: pulmonary rehab | Referrals: pulmonary rehab | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): Referrals: smoking cessation counseling | Referrals: smoking cessation counseling | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| Effectiveness (clinical outcomes): Referrals: specialist care | Referrals: specialist care | outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up. |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |